IRB Infrastructure on Monday said its board has approved the sale of its Gandeva Ena (VM7) hybrid annuity model project, ...

IRB Infrastructure has announced the approval for selling its Gandeva Ena HAM project to IRB InvIT Fund for Rs 513 crore.

IRB Infra to sell Gandeva Ena HAM project to IRB InvIT Fund for ₹513 crore. Project is part of Delhi Mumbai Expressway.

60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine, marketed as ...

(RTTNews) - Clearmind Medicine Inc. (CMND), a clinical-stage biotech company developing psychedelic-derived treatments, has received Institutional Review Board or IRB approval from Tel Aviv Sourasky ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health ...

HOUSTON, TX, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, ...

Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the ...

The MarketWatch News Department was not involved in the creation of this content. -Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire ...

DOWNINGTON, Pa., Oct. 9, 2025 /PRNewswire/ -- Vytala, a healthcare-focused food technology company, today announced important milestones for Seracal™, its novel medical food designed to address fat ...

In this free webinar, gain insight into best practices for collaboration between sponsors, CROs and IRBs to reduce revision cycles and increase predictability in timelines. The featured speakers will ...

Modular Medical (MODD) announced Institutional Review Board approval to conduct an in-house study of its next-generation Pivot insulin delivery ...